Overview Financials News + Filings Key Docs Charts Transactions Holdings Ownership Insiders
|
ABBOTT BIOTHERAPEUTICS CORP (FACT)
|
|
Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
In millions, except per share items | Dec-31-09 | Dec-31-08 | Dec-31-07 | Dec-31-06 |
| 8-K | 10-K | 10-K | 10-K |
Revenues | 100.0% | 100.0% | 100.0% | 100.0% |
Cost of goods sold | 0.0% | 0.0% | 0.0% | 0.0% |
Gross profit | 100.0% | 100.0% | 100.0% | 100.0% |
Research and development | 265.0% | 828.3% | 731.0% | 390.4% |
General and administrative | 82.6% | 253.7% | 168.8% | 71.2% |
EBITDA | | -871.5% | -686.8% | -303.2% |
Depreciation | | 101.5% | 106.8% | 54.8% |
EBITA | -247.6% | -973.0% | -793.6% | -358.0% |
Amortization of intangibles | | 9.0% | 6.2% | 3.5% |
EBIT | -247.6% | -982.1% | -799.8% | -361.5% |
Pre-tax income | -307.3% | -885.6% | -851.1% | -362.9% |
Income taxes | 0.0% | 0.4% | 0.5% | 0.2% |
Net income | -307.3% | -886.0% | -851.6% | -363.1% |
|